Effect of Pulsed Electromagnetic Field and Exercise Therapy in treatment of Osteoporosis

Not Applicable

Recruiting

• Conditions: Osteoporosis.; Age-related osteoporosis without current pathological fracture; M81.0

• Registration Number: IRCT20221202056687N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 36

Inclusion Criteria

women at the age of 55-68, having reached menopause at least 5 year before the study.
A body mass index of 22-30
T-score for the hip or lumbar spine -2.5 SD or less.
do not have a history of overioectomy syrgery
Do not have a history of osteoporosis fracture

Exclusion Criteria

Participating in sports regularly for at least one year before starting the study (regular exercise means at least 30 minutes a day and 3 days a week)
Taking drugs that affect bone metabolism, except for daily calcium and vitamin D and weekly alendronite tablets, which will be prescribed by the rheumatology consultant of the study with the same dose for all participants.
The presence of any medical problem affecting the person's movement (diabetes - diseases of the vestibular system - uncorrected vision or hearing disorders - neurological diseases
A history of surgery in the spine and pelvis and the use of tools to fix it or a history of surgery in the lower limbs
• History of hormone therapy in the last 6 months
A history of having cardiovascular diseases, such as uncontrolled blood pressure, which will be considered as an exclusion criterion for groups that will do exercise therapy
Using physiotherapy modalities effective on bone metabolism, such as using WBV, LPL, PEMF modalities in the last 6 month
Using tranquilizers (Tranquillizer) in both minor classifications (anti-anxiety, diazepam, oxazepam, alprazolam, etc.) and major (antipsychotic drugs such as haloperidol, phenotazines, fluphenazine, etc.) in three last month
Unwillingness of the samples to continue the treatment and not participating regularly in the treatment program
A change in sample conditions that would result in missing one of the inclusion criteria

Study & Design

• Study Type: interventional
• Study Design: Not specified